Dimetindene Maleate
This medicine should always be used exactly as described in this package leaflet for the patient, or as directed by a doctor or pharmacist.
Dimastin is a gel for application to the skin. Dimastin contains the active substance dimetindene maleate, which inhibits the action of histamine - a compound responsible for allergic reactions.
The medicine applied to the skin acts locally as an antihistamine, strongly anti-itching (excluding cholestatic itching), reduces swelling, and soothes irritations.
It exhibits local anesthetic properties. It cools, which further soothes irritated skin.
Relieving itching associated with skin diseases, such as skin rashes and urticaria, as well as in the case of insect bites, sunburns, and superficial skin burns of the first degree (skin redness).
Dimastin is indicated for use in adults, adolescents, and children from the age of 1 year and older.
Before starting to use Dimastin, discuss it with your doctor or pharmacist.
In the case of applying the Dimastin gel to a large area of skin, avoid exposing the areas covered by it to sunlight.
Inform your doctor in case of very strong itching or extensive changes.
If the symptoms worsen or persist, the patient feels worse, or if the use of the medicine is required for longer than 2 days in children and 7 days in adults and adolescents, consult a doctor.
Avoid using the medicine in small children on large areas of skin, especially in cases of injuries, burns, and skin inflammation.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or plan to take.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, consult your doctor or pharmacist before using this medicine.
There is no experience with the use of Dimastin in pregnant and breastfeeding women.
Dimastin should not be used in pregnant and breastfeeding women, unless the doctor recommends otherwise.
During pregnancy and breastfeeding, do not use the medicine on large areas of skin, especially if it is injured or inflamed.
During breastfeeding, do not apply to the nipples. For further information, see "Dimastin contains benzalkonium chloride and propylene glycol (E 1520)".
Dimastin has no influence or negligible influence on the ability to drive and use machines.
The medicine contains 0.05 mg of benzalkonium chloride in each gram of gel. Benzalkonium chloride may irritate the skin.
Breastfeeding women should not use this medicine on the breast skin, as it may be ingested by the child with breast milk.
The medicine contains 150 mg of propylene glycol (E 1520) in each gram of gel. Propylene glycol may cause skin irritation.
This medicine should always be used exactly as described in this package leaflet for the patient, or as directed by a doctor or pharmacist. In case of doubts, consult a doctor or pharmacist.
The medicine is intended for application to the skin.
Usually, unless the doctor recommends otherwise, the medicine should be applied 2 to 4 times a day, covering the affected and itchy skin surface with a thin layer of gel.
If the symptoms worsen or persist, the patient feels worse, or if the use of the medicine is required for longer than 2 days in children and 7 days in adults and adolescents, consult a doctor.
No cases of overdose with dimetindene maleate applied topically to the skin have been reported.
In case of ingestion of the medicine, consult a doctor immediately.
Do not use a double dose to make up for a missed dose.
In case of any further doubts regarding the use of this medicine, consult a doctor or pharmacist.
Like all medicines, Dimastin can cause side effects, although not everybody gets them.
Frequency not known (cannot be estimated from the available data):
If you experience any side effects, including those not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of the medicine.
Keep the medicine out of the sight and reach of children.
There are no special precautions for storage temperature.
Store in the original packaging to protect from light.
Shelf life after first opening the tube: 18 months.
Do not use this medicine after the expiry date stated on the carton and tube after "EXP".
The expiry date refers to the last day of the given month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Dimastin is a transparent, colorless to light yellow, odorless, homogeneous gel.
Packaging: aluminum tube with a sealing membrane, coated internally with epoxy-phenolic varnish, with a polyethylene (HDPE) screw cap equipped with a piercer, placed together with the leaflet in a cardboard box.
Pack size: 30 g
ZIAJA Ltd Pharmaceutical Works Ltd.
ul. Jesienna 9
80-298 Gdańsk
Poland
Phone: +48 58 521 34 00
ZIAJA Ltd Pharmaceutical Works Ltd.
ul. Przemysłowa 12
83-050 Kolbudy
Poland
Poland: Dimastin
Czech Republic: Fanin
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.